Who owns Regeneron Pharmaceuticals?

Key details on Regeneron Pharmaceuticals (Ticker: REGN)

Who owns Regeneron Pharmaceuticals?

Is REGN a good stock to own? Find out who bought Regeneron Pharmaceuticals, who sold Regeneron Pharmaceuticals (REGN) stock, and who holds a large position in Regeneron Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Capital World Investors^ 7.35M $2.08B June 30, 2014
FMR 5.74M $1.72B March 31, 2014
Wellington Management Company 5.67M $1.60B June 30, 2014
Sands Capital Management 4.91M $1.39B June 30, 2014
Artisan Partners Holdings 4.17M $236.54M June 30, 2011
Vanguard 3.91M $1.11B June 30, 2014
STATE STREET CORPORATION 3.23M $912.14M June 30, 2014
Artisan Partners Limited Partnership 3.19M $901.65M June 30, 2014
VIKING GLOBAL INVESTORS 2.96M $837.09M June 30, 2014
T. Rowe Price Associates 2.79M $789.31M June 30, 2014
Icahn Capital 2.44M $109.84M March 31, 2011
BlackRock Institutional Trust Company, N.A. 2.00M $722.52M Sept. 30, 2014
BlackRock Fund Advisors 1.91M $686.80M Sept. 30, 2014
JPMORGAN CHASE & CO 1.68M $474.67M June 30, 2014
Wells Fargo & Company 1.65M $466.47M June 30, 2014
SUSQUEHANNA INTERNATIONAL 1.45M $435.11M March 31, 2014
Jefferies 1.34M $156.56M March 31, 2012
Inves 1.32M $397.73M March 31, 2014
Citi 1.32M $73.23M Dec. 31, 2011
GOLDMAN SACHS 1.16M $348.20M March 31, 2014
Gail Mannix 1.14M $133.46M March 31, 2012
Franklin Resources 1.12M $335.15M March 31, 2014
Deutsche Bank Aktiengesellschaft 1.11M $345.81M Sept. 30, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.10M $396.49M Sept. 30, 2014
Schroder Investment Management 1.08M $339.08M Sept. 30, 2013
NORTHERN TRUST 1.06M $319.18M March 31, 2014

Who sold Regeneron Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
GRANAHAN INVESTMENT MANAGEMENT INC/MA June 30, 2011 1.07M $60.41M
Ridgeback Capital Investments March 31, 2011 1.90M $85.39M
Visium Asset Management March 31, 2011 1.23M $55.33M
QVT Financial March 31, 2011 1.16M $51.96M